Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cincinnati Financial Corporation (CINF) vs GeneDx Holdings Corp (WGS) Price & Performance

Cincinnati Financial CorporationTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Cincinnati Financial Corporation vs GeneDx Holdings Corp — how do they compare? Cincinnati Financial Corporation trades at $172.54 (market cap $26.58B), while GeneDx Holdings Corp trades at $82.51 (market cap $2.44B). The key difference: Cincinnati Financial Corporation is far larger — about 10.9× GeneDx Holdings Corp's market cap, and Cincinnati Financial Corporation pays a 2.17% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

CINFWGS
Market Cap
$26.58B$2.44B
Sector
FinancialsTechnology
52-Week High
$192.03$167.51
52-Week Low
$149.79$34.51
Enterprise Value
$25.71B$2.48B
Dividend Yield
2.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cincinnati Financial Corporation

Cincinnati Financial (CINF) trades at $172.87, down 0.57% on the day, with a bearish technical signal despite strong fundamentals. The company reported Q2 2026 earnings miss ($1.43 vs. $1.84 expected) but maintains robust revenue growth and profitability with a 23.84% net income margin. Cash flow trends show improvement, with 2025 net cash flow reaching $448 million. Analyst consensus remains positive with a $195 price target, though technical indicators suggest near-term pressure.

CINF presents a value opportunity with attractive valuation metrics (P/E 8.18, P/B 1.59) and consistent dividend growth. Key risks include catastrophe losses impacting underwriting results and commercial lines performance. The stock's current technical weakness may offer entry points for long-term investors seeking quality insurance exposure with strong ROE of 21.48%.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.

Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.

Returns comparison

Trailing returns across standard periods

About Cincinnati Financial Corporation

Cincinnati Financial Corp is a property and casualty insurance company that generates income through written premiums. A select group of independent agencies actively markets the company's business, home, and automotive insurance within their communities. These agents offer the company's personal lines as well as its standard market, excess, and surplus commercial line policies in many regions in the United States. Cincinnati Financial also offers leasing and financing services. The vast majority of the company's revenue is generated through commercial lines, followed by personal lines.

Read more on CINF

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS